Josephine Schultz

Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.

Bruce J. Giantonio, R. Katherine Alpaugh, Josephine Schultz et al. · Journal of Clinical Oncology · 1997 · 82 citations

A randomized trial of first-line irinotecan/fluoropymidine combinations with or without celecoxib in metastatic colorectal cancer (BICC-C)

Charles S. Fuchs, J. Marshall, Edith P. Mitchell et al. · Journal of Clinical Oncology · 2006 · 54 citations

Gastrointestinal Oncology, Medicine, Celecoxib Vs Placebo +15

Superantigen-targeted therapy: phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies.

R. Katherine Alpaugh, Josephine Schultz, C McAleer et al. · PubMed · 1998 · 40 citations

Immunotoxicology, Immunology, Pathology +20

Updated results of BICC-C study comparing first-line irinotecan/fluoropymidine combinations with or without celecoxib in mCRC: Updated efficacy data

Charles S. Fuchs, John L. Marshall, E. Mitchell et al. · Journal of Clinical Oncology · 2007 · 28 citations

Pharmacotherapy, Antimicrobial Chemotherapy, Clinical Trials +16

Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment

John I. Clark, R. Katherine Alpaugh, Margaret von Mehren et al. · Cancer Immunology Immunotherapy · 1997 · 19 citations · Full text

Allergy, Autoimmune Disease, Multiple Anti-c-erbb-2 Specificities +9